The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on abrdn Latin American

1 Mar 2022 07:00

RNS Number : 0805D
abrdn Latin American Income Fund Ld
01 March 2022
 

 

London, UK, 1 March 2022

 

Edison issues review on abrdn Latin American Income Fund (ALAI)

abrdn Latin American Income Fund's (ALAI) managers at abrdn Capital International (abrdn) consider that Latin American equity and fixed-income assets are 'extremely inexpensive'. The region has underperformed both other emerging and developed markets in recent years despite commodity price strength, while the managers believe that Latin American political risk is already priced into the markets. They report that ALAI's portfolio has significant exposure to positive structural trends such as electrification. As an example, Chile and Peru are leading lithium and nickel producers and these materials are in high demand. The managers suggest that this trend could continue for many decades, given the long-term transition to a greener global economy.

ALAI is currently trading at an 11.6% share price discount to cum-income NAV, which compares with a range of 3.1% to 16.8% range of discounts over the last 12 months and an 11.2% to 13.2% range of average discounts over the last one, three and five years. ALAI's annual dividend has held steady at 3.50p per share for the last six consecutive financial years, drawing on revenue reserves when required, and the fund offers an attractive 6.7% yield.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Sarah Godfrey +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQVLFLLLLLBBL
Date   Source Headline
27th Feb 202312:36 pmRNSNet Asset Value(s)
24th Feb 20231:33 pmRNSNet Asset Value(s)
23rd Feb 202311:41 amRNSNet Asset Value(s)
22nd Feb 202311:37 amRNSNet Asset Value(s)
21st Feb 202310:59 amRNSNet Asset Value(s)
20th Feb 20231:35 pmRNSGearing disclosure
20th Feb 202312:37 pmRNSNet Asset Value(s)
17th Feb 202312:34 pmRNSNet Asset Value(s)
16th Feb 202312:07 pmRNSNet Asset Value(s)
15th Feb 202311:31 amRNSNet Asset Value(s)
14th Feb 20234:07 pmRNSPortfolio disclosure
14th Feb 202312:28 pmRNSNet Asset Value(s)
13th Feb 20233:48 pmRNSGearing disclosure
13th Feb 202312:30 pmRNSNet Asset Value(s)
10th Feb 202312:41 pmRNSNet Asset Value(s)
9th Feb 20231:05 pmRNSNet Asset Value(s)
8th Feb 20231:24 pmRNSNet Asset Value(s)
7th Feb 20231:29 pmRNSNet Asset Value(s)
6th Feb 20234:04 pmRNSMonth End Net Asset Value(s)
6th Feb 20232:43 pmRNSGearing Disclosures
6th Feb 202312:09 pmRNSNet Asset Value(s)
3rd Feb 202312:23 pmRNSNet Asset Value(s)
2nd Feb 20231:01 pmRNSNet Asset Value(s)
31st Jan 202312:34 pmRNSNet Asset Value(s)
30th Jan 20232:10 pmRNSGearing disclosure
30th Jan 202312:31 pmRNSNet Asset Value(s)
27th Jan 202312:09 pmRNSNet Asset Value(s)
26th Jan 20234:14 pmRNSHolding(s) in Company
26th Jan 202312:00 pmRNSNet Asset Value(s)
25th Jan 202312:32 pmRNSNet Asset Value(s)
24th Jan 202312:59 pmRNSNet Asset Value(s)
23rd Jan 20234:23 pmRNSGearing disclosure
23rd Jan 202312:35 pmRNSNet Asset Value(s)
20th Jan 202312:48 pmRNSNet Asset Value(s)
19th Jan 202312:43 pmRNSNet Asset Value(s)
18th Jan 20235:10 pmRNSNet Asset Value(s)
18th Jan 202310:53 amRNSPortfolio disclosure
17th Jan 202312:19 pmRNSNet Asset Value(s)
16th Jan 20232:12 pmRNSGearing disclosure
16th Jan 20231:05 pmRNSNet Asset Value(s)
13th Jan 20231:08 pmRNSNet Asset Value(s)
12th Jan 202312:05 pmRNSNet Asset Value(s)
11th Jan 202311:10 amRNSNet Asset Value(s)
10th Jan 202312:02 pmRNSNet Asset Value(s)
9th Jan 20235:18 pmRNSGearing disclosure
9th Jan 202312:13 pmRNSNet Asset Value(s)
6th Jan 20233:03 pmRNSMonth End Net Asset Value(s)
6th Jan 202312:52 pmRNSNet Asset Value(s)
5th Jan 202312:11 pmRNSNet Asset Value(s)
4th Jan 202312:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.